(Q46669969)
English
Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP al
scientific article published on 25 August 2005
Statements
1 reference
Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP al (English)
1 reference
Martin Dreyling
1 reference
Michael Unterhalt
1 reference
Wolfgang Hiddemann
1 reference
Michael Kneba
1 reference
Norbert Schmitz
1 reference
Eva Lengfelder
1 reference
Rudolf Schmits
1 reference
Marcel Reiser
1 reference
Bernd Metzner
1 reference
Harriet Harder
1 reference
Susanna Hegewisch-Becker
1 reference
Thomas Fischer
1 reference
Martin Kropff
1 reference
Hans-Edgar Reis
1 reference
Mathias Freund
1 reference
Bernhard Wörmann
1 reference
Roland Fuchs
1 reference
Manfred Planker
1 reference
Jörg Schimke
1 reference
Hartmut Eimermacher
1 reference
Lorenz Trümper
1 reference
Ali Aldaoud
1 reference
Reza Parwaresch
1 reference
25 August 2005
1 reference
1 reference
106
1 reference
12
1 reference
3725-3732
1 reference
Identifiers
1 reference